A novel PDHK inhibitor restored cognitive dysfunction and limited neurodegeneration without affecting amyloid pathology in 5xFAD mouse, a model of Alzheimer’s disease

By sjmartinez • September 6, 2024

Sakimura K, Kawai T, Nashida R, Ishida Y, Harada K, Suzuki T, Okuma C, Cole GM. A novel PDHK inhibitor restored cognitive dysfunction and limited neurodegeneration without affecting amyloid pathology in 5xFAD mouse, a model of Alzheimer's disease. Alzheimers Res Ther. 2024 Sep 5;16(1):197. doi: 10.1186/s13195-024-01552-2. PMID: 39238036.

Tags: 5xFAD, Aerobic glycolysis, Alzheimer’s disease, Geriatrics, Glucose metabolism, GRECC, PDH, PDHK, Publications, Pyruvate dehydrogenase, Pyruvate dehydrogenase kinase, Veterans Administration

Related Posts

JAGS Remains Committed to Scientific Principles That Support Better Health and Function for All Older Adults: Disparities, Diversity in Research, and Respectful Discourse

Smith AK, Saliba D, Abadir PM, Binder E, Borson S, Cobbs EL, Marcantonio ER, Rochon PA, Travers JL, Fernandez HM, Rhodes R, Ouslander JG. JAGS[...]

The relation of heavy or prolonged bleeding during the menopause transition to risk of hysterectomy

Harlow SD, Hood MM, Mukwege A, Randolph JF Jr, Gold EB, Elliott MR, White AC, Greendale GA. The relation of heavy or prolonged bleeding during[...]

Impact of multifactorial interventions with medication and lifestyle optimization on patients with type 2 diabetes: A randomised controlled trial

El-Deyarbi M, Ahmed L, King J, Adi ZS, Al Juboori A, Mansour NA, Al Nuaimi H, Beiram R, Aburuz S. Impact of multifactorial interventions with[...]